Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines.
Identifieur interne : 000B45 ( Main/Exploration ); précédent : 000B44; suivant : 000B46Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines.
Auteurs : E. Papadavid [Grèce] ; J. Scaribrick [Royaume-Uni] ; P. Ortiz Romero [Espagne] ; P. Guaglino [Italie] ; M. Vermeer [Pays-Bas] ; R. Knobler [Autriche] ; R. Stadler [Allemagne] ; M. Bagot [France]Source :
- Journal of the European Academy of Dermatology and Venereology : JEADV [ 1468-3083 ] ; 2020.
Descripteurs français
- KwdFr :
- Betacoronavirus (isolement et purification), Guides de bonnes pratiques cliniques comme sujet (MeSH), Humains (MeSH), Infections à coronavirus (complications), Infections à coronavirus (virologie), Infections à coronavirus (épidémiologie), Lymphome T cutané (complications), Lymphome T cutané (thérapie), Pandémies (MeSH), Pneumopathie virale (complications), Pneumopathie virale (virologie), Pneumopathie virale (épidémiologie), Tumeurs cutanées (complications), Tumeurs cutanées (thérapie).
- MESH :
- isolement et purification : Betacoronavirus.
- thérapie : Lymphome T cutané, Tumeurs cutanées.
- virologie : Infections à coronavirus, Pneumopathie virale.
- épidémiologie : Infections à coronavirus, Pneumopathie virale.
- complications : Guides de bonnes pratiques cliniques comme sujet, Humains, Infections à coronavirus, Lymphome T cutané, Pandémies, Pneumopathie virale, Tumeurs cutanées.
English descriptors
- KwdEn :
- Betacoronavirus (isolation & purification), Coronavirus Infections (complications), Coronavirus Infections (epidemiology), Coronavirus Infections (virology), Humans (MeSH), Lymphoma, T-Cell, Cutaneous (complications), Lymphoma, T-Cell, Cutaneous (therapy), Pandemics (MeSH), Pneumonia, Viral (complications), Pneumonia, Viral (epidemiology), Pneumonia, Viral (virology), Practice Guidelines as Topic (MeSH), Skin Neoplasms (complications), Skin Neoplasms (therapy).
- MESH :
- complications : Coronavirus Infections, Lymphoma, T-Cell, Cutaneous, Pneumonia, Viral, Skin Neoplasms.
- epidemiology : Coronavirus Infections, Pneumonia, Viral.
- isolation & purification : Betacoronavirus.
- therapy : Lymphoma, T-Cell, Cutaneous, Skin Neoplasms.
- virology : Coronavirus Infections, Pneumonia, Viral.
- Humans, Pandemics, Practice Guidelines as Topic.
DOI: 10.1111/jdv.16593
PubMed: 32416629
PubMed Central: PMC7276772
Affiliations:
- Allemagne, Autriche, Espagne, France, Grèce, Italie, Pays-Bas, Royaume-Uni
- Angleterre, Attique (région), Communauté de Madrid, Hollande-Méridionale, Midlands de l'Ouest, Piémont, Vienne (Autriche), Île-de-France
- Athènes, Birmingham, Leyde, Madrid, Paris, Turin, Vienne (Autriche)
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines.</title><author><name sortKey="Papadavid, E" sort="Papadavid, E" uniqKey="Papadavid E" first="E" last="Papadavid">E. Papadavid</name><affiliation wicri:level="3"><nlm:affiliation>2nd Dermatology Department, National and Kapodistrian University of Athens, Athens, Greece.</nlm:affiliation><country xml:lang="fr">Grèce</country><wicri:regionArea>2nd Dermatology Department, National and Kapodistrian University of Athens, Athens</wicri:regionArea><placeName><settlement type="city">Athènes</settlement><region nuts="2" type="region">Attique (région)</region></placeName></affiliation></author><author><name sortKey="Scaribrick, J" sort="Scaribrick, J" uniqKey="Scaribrick J" first="J" last="Scaribrick">J. Scaribrick</name><affiliation wicri:level="3"><nlm:affiliation>University Hospital Birmingham, Birmingham, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>University Hospital Birmingham, Birmingham</wicri:regionArea><placeName><settlement type="city">Birmingham</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Midlands de l'Ouest</region></placeName></affiliation></author><author><name sortKey="Ortiz Romero, P" sort="Ortiz Romero, P" uniqKey="Ortiz Romero P" first="P" last="Ortiz Romero">P. Ortiz Romero</name><affiliation wicri:level="3"><nlm:affiliation>Dermatology Department, University 12 of Octubre, Madrid, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Dermatology Department, University 12 of Octubre, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Guaglino, P" sort="Guaglino, P" uniqKey="Guaglino P" first="P" last="Guaglino">P. Guaglino</name><affiliation wicri:level="3"><nlm:affiliation>Department of Dermatology, University of Turin, Turin, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Dermatology, University of Turin, Turin</wicri:regionArea><placeName><settlement type="city">Turin</settlement><region type="région" nuts="2">Piémont</region></placeName></affiliation></author><author><name sortKey="Vermeer, M" sort="Vermeer, M" uniqKey="Vermeer M" first="M" last="Vermeer">M. Vermeer</name><affiliation wicri:level="3"><nlm:affiliation>University of Leiden, Leiden, Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>University of Leiden, Leiden</wicri:regionArea><placeName><settlement type="city">Leyde</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author><author><name sortKey="Knobler, R" sort="Knobler, R" uniqKey="Knobler R" first="R" last="Knobler">R. Knobler</name><affiliation wicri:level="3"><nlm:affiliation>Department of Dermatology, Medical University of Vienna, Vienna, Austria.</nlm:affiliation><country xml:lang="fr">Autriche</country><wicri:regionArea>Department of Dermatology, Medical University of Vienna, Vienna</wicri:regionArea><placeName><settlement type="city">Vienne (Autriche)</settlement><region nuts="2" type="province">Vienne (Autriche)</region></placeName></affiliation></author><author><name sortKey="Stadler, R" sort="Stadler, R" uniqKey="Stadler R" first="R" last="Stadler">R. Stadler</name><affiliation wicri:level="1"><nlm:affiliation>Department of Dermatology, Venerology, Allergology und Phlebology, Johannes Wesling Klinikum Minden, Minden, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Dermatology, Venerology, Allergology und Phlebology, Johannes Wesling Klinikum Minden, Minden</wicri:regionArea><wicri:noRegion>Minden</wicri:noRegion><wicri:noRegion>Minden</wicri:noRegion><wicri:noRegion>Minden</wicri:noRegion></affiliation></author><author><name sortKey="Bagot, M" sort="Bagot, M" uniqKey="Bagot M" first="M" last="Bagot">M. Bagot</name><affiliation wicri:level="3"><nlm:affiliation>University of Paris, Hospital Saint-Louis, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>University of Paris, Hospital Saint-Louis, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32416629</idno><idno type="pmid">32416629</idno><idno type="doi">10.1111/jdv.16593</idno><idno type="pmc">PMC7276772</idno><idno type="wicri:Area/Main/Corpus">001270</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001270</idno><idno type="wicri:Area/Main/Curation">001270</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001270</idno><idno type="wicri:Area/Main/Exploration">001270</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines.</title><author><name sortKey="Papadavid, E" sort="Papadavid, E" uniqKey="Papadavid E" first="E" last="Papadavid">E. Papadavid</name><affiliation wicri:level="3"><nlm:affiliation>2nd Dermatology Department, National and Kapodistrian University of Athens, Athens, Greece.</nlm:affiliation><country xml:lang="fr">Grèce</country><wicri:regionArea>2nd Dermatology Department, National and Kapodistrian University of Athens, Athens</wicri:regionArea><placeName><settlement type="city">Athènes</settlement><region nuts="2" type="region">Attique (région)</region></placeName></affiliation></author><author><name sortKey="Scaribrick, J" sort="Scaribrick, J" uniqKey="Scaribrick J" first="J" last="Scaribrick">J. Scaribrick</name><affiliation wicri:level="3"><nlm:affiliation>University Hospital Birmingham, Birmingham, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>University Hospital Birmingham, Birmingham</wicri:regionArea><placeName><settlement type="city">Birmingham</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Midlands de l'Ouest</region></placeName></affiliation></author><author><name sortKey="Ortiz Romero, P" sort="Ortiz Romero, P" uniqKey="Ortiz Romero P" first="P" last="Ortiz Romero">P. Ortiz Romero</name><affiliation wicri:level="3"><nlm:affiliation>Dermatology Department, University 12 of Octubre, Madrid, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Dermatology Department, University 12 of Octubre, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Guaglino, P" sort="Guaglino, P" uniqKey="Guaglino P" first="P" last="Guaglino">P. Guaglino</name><affiliation wicri:level="3"><nlm:affiliation>Department of Dermatology, University of Turin, Turin, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Dermatology, University of Turin, Turin</wicri:regionArea><placeName><settlement type="city">Turin</settlement><region type="région" nuts="2">Piémont</region></placeName></affiliation></author><author><name sortKey="Vermeer, M" sort="Vermeer, M" uniqKey="Vermeer M" first="M" last="Vermeer">M. Vermeer</name><affiliation wicri:level="3"><nlm:affiliation>University of Leiden, Leiden, Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>University of Leiden, Leiden</wicri:regionArea><placeName><settlement type="city">Leyde</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author><author><name sortKey="Knobler, R" sort="Knobler, R" uniqKey="Knobler R" first="R" last="Knobler">R. Knobler</name><affiliation wicri:level="3"><nlm:affiliation>Department of Dermatology, Medical University of Vienna, Vienna, Austria.</nlm:affiliation><country xml:lang="fr">Autriche</country><wicri:regionArea>Department of Dermatology, Medical University of Vienna, Vienna</wicri:regionArea><placeName><settlement type="city">Vienne (Autriche)</settlement><region nuts="2" type="province">Vienne (Autriche)</region></placeName></affiliation></author><author><name sortKey="Stadler, R" sort="Stadler, R" uniqKey="Stadler R" first="R" last="Stadler">R. Stadler</name><affiliation wicri:level="1"><nlm:affiliation>Department of Dermatology, Venerology, Allergology und Phlebology, Johannes Wesling Klinikum Minden, Minden, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Dermatology, Venerology, Allergology und Phlebology, Johannes Wesling Klinikum Minden, Minden</wicri:regionArea><wicri:noRegion>Minden</wicri:noRegion><wicri:noRegion>Minden</wicri:noRegion><wicri:noRegion>Minden</wicri:noRegion></affiliation></author><author><name sortKey="Bagot, M" sort="Bagot, M" uniqKey="Bagot M" first="M" last="Bagot">M. Bagot</name><affiliation wicri:level="3"><nlm:affiliation>University of Paris, Hospital Saint-Louis, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>University of Paris, Hospital Saint-Louis, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author></analytic><series><title level="j">Journal of the European Academy of Dermatology and Venereology : JEADV</title><idno type="eISSN">1468-3083</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Betacoronavirus (isolation & purification)</term><term>Coronavirus Infections (complications)</term><term>Coronavirus Infections (epidemiology)</term><term>Coronavirus Infections (virology)</term><term>Humans (MeSH)</term><term>Lymphoma, T-Cell, Cutaneous (complications)</term><term>Lymphoma, T-Cell, Cutaneous (therapy)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (complications)</term><term>Pneumonia, Viral (epidemiology)</term><term>Pneumonia, Viral (virology)</term><term>Practice Guidelines as Topic (MeSH)</term><term>Skin Neoplasms (complications)</term><term>Skin Neoplasms (therapy)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Betacoronavirus (isolement et purification)</term><term>Guides de bonnes pratiques cliniques comme sujet (MeSH)</term><term>Humains (MeSH)</term><term>Infections à coronavirus (complications)</term><term>Infections à coronavirus (virologie)</term><term>Infections à coronavirus (épidémiologie)</term><term>Lymphome T cutané (complications)</term><term>Lymphome T cutané (thérapie)</term><term>Pandémies (MeSH)</term><term>Pneumopathie virale (complications)</term><term>Pneumopathie virale (virologie)</term><term>Pneumopathie virale (épidémiologie)</term><term>Tumeurs cutanées (complications)</term><term>Tumeurs cutanées (thérapie)</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Coronavirus Infections</term><term>Lymphoma, T-Cell, Cutaneous</term><term>Pneumonia, Viral</term><term>Skin Neoplasms</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Betacoronavirus</term></keywords><keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Betacoronavirus</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Lymphoma, T-Cell, Cutaneous</term><term>Skin Neoplasms</term></keywords><keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Lymphome T cutané</term><term>Tumeurs cutanées</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Pandemics</term><term>Practice Guidelines as Topic</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="fr"><term>Guides de bonnes pratiques cliniques comme sujet</term><term>Humains</term><term>Infections à coronavirus</term><term>Lymphome T cutané</term><term>Pandémies</term><term>Pneumopathie virale</term><term>Tumeurs cutanées</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32416629</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>21</Day></DateCompleted><DateRevised><Year>2020</Year><Month>08</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-3083</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of the European Academy of Dermatology and Venereology : JEADV</Title><ISOAbbreviation>J Eur Acad Dermatol Venereol</ISOAbbreviation></Journal><ArticleTitle>Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines.</ArticleTitle><Pagination><MedlinePgn>1633-1636</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jdv.16593</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Papadavid</LastName><ForeName>E</ForeName><Initials>E</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-8634-102X</Identifier><AffiliationInfo><Affiliation>2nd Dermatology Department, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scaribrick</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University Hospital Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ortiz Romero</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Dermatology Department, University 12 of Octubre, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guaglino</LastName><ForeName>P</ForeName><Initials>P</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-4185-9586</Identifier><AffiliationInfo><Affiliation>Department of Dermatology, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vermeer</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Leiden, Leiden, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knobler</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stadler</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Venerology, Allergology und Phlebology, Johannes Wesling Klinikum Minden, Minden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bagot</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Paris, Hospital Saint-Louis, Paris, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Eur Acad Dermatol Venereol</MedlineTA><NlmUniqueID>9216037</NlmUniqueID><ISSNLinking>0926-9959</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName><SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016410" MajorTopicYN="N">Lymphoma, T-Cell, Cutaneous</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="N">Practice Guidelines as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012878" MajorTopicYN="N">Skin Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>04</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>04</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>04</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32416629</ArticleId><ArticleId IdType="doi">10.1111/jdv.16593</ArticleId><ArticleId IdType="pmc">PMC7276772</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>Guan WJ, Ni ZY, Hu Y et al.Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382: 1708-1720.</Citation></Reference><Reference><Citation>Zhou F, Yu T, Du R et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395: 1054-1062.</Citation></Reference><Reference><Citation>Liang W, Guan WChen R et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020; 21: 335-337.</Citation></Reference><Reference><Citation>von Lilienfeld-Toal M, Vehreschild JJ, Cornely O, Pagano P, Compagno FHirsch HH.European Hematology Association scientific working group infections in Hematology. Frequently asked questions regarding SARS-CoV2 in cancer patients: Recommendations for clinicians caring for patients with malignant diseases 2020. Available at https://ehaweb.org/guidelines/covid-19/.</Citation></Reference><Reference><Citation>Ueda M, Martins R, Hendrie PC et al. Managing cancer care during the COVID19 pandemic: agility and collaboration toward a common goal. J Natl Compr Canc Netw 2020; 18: 366-369.</Citation></Reference><Reference><Citation>HermanHermann B, Lehners N, Brodhun M et al. Influenza virus infections in patients with malignancies - characteristics and outcome of the season 2014/15. A survey conducted by the Infectious Diseases Working Party (AGIHO) of the German Society of Haematology and Medical Oncology (DGHO). Eur J Clin Microbiol Infect Dis. 2017; 36: 565-573.</Citation></Reference><Reference><Citation>Girardi M, Heald PW, Wilson LD. Τhe pathogenesis of mycosis fungoides. N Engl J Med 2004;350: 1978-1988</Citation></Reference><Reference><Citation>Willemze R, Cerroni L, Kempf W. The update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood 2019; 133: 1703-1714.</Citation></Reference><Reference><Citation>Li JY, Horwitz S, Moskowitz A, Myskowski PL, Pulitzer M. Querfeld CManagement of cutaneous T cell lymphoma: new and emerging targets and treatment options. Cancer Manag Res 2012; 4: 75-89.</Citation></Reference><Reference><Citation>Willemze R. Cutaneous T cell lymphoma: epidemiology, etiology and classification. Leuk Lymphoma 2003; 44(Suppl 3): S49-54.</Citation></Reference><Reference><Citation>Nikolaou V, Papadavid E, Patsatsi A et al. Prognostic indicators for mycosis fungoides in a Greek population. Br J Dermatol 2017; 176: 1321-1330.</Citation></Reference><Reference><Citation>Radford PT, Devesa SS, Anderson WFToro JR. Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood 2009;113: 5064-5073.</Citation></Reference><Reference><Citation>Scarisbrick JJ, Kim YH, Whittaker SJ et al. Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now? Br J Dermatol 2014; 170:1226-1236.</Citation></Reference><Reference><Citation>Swerdlow SH, Campo E, Pileri SA et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016; 127: 2375-2390.</Citation></Reference><Reference><Citation>Wernham AG, Shah F, Amel-Kashipaz R, Cobbold MScarisbrick J. Stage I mycosis fungoides: frequent association with a favourable prognosis but disease progression and disease-specific mortality may occur. Br J Dermatol 2015; 173: 1295-1297.</Citation></Reference><Reference><Citation>Scarisbrick JJ, Quaglino P, Prince HM et al. The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients. Br J Dermatol 2019; 181: 350-357.</Citation></Reference><Reference><Citation>Mourad AGniadecki R. Overall survival in mycosis fungoides: a systematic review and meta-analysis. J Invest Dermatol 2020; 140:495-497.e5.</Citation></Reference><Reference><Citation>Scarisbrick JJ. Survival in Mycosis Fungoides and Sezary Syndrome: How can we predict outcome? J Invest Dermatol 2020; 140: 281-283.</Citation></Reference><Reference><Citation>Trautinger F, Eder J, Assaf C et al. European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017. Eur J Cancer 2017; 77: 57-74.</Citation></Reference><Reference><Citation>Molloy K, Jonak C, Woei-A-Jin FJSH et al. Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study. Br J Dermatol 2020; 182: 770-779.</Citation></Reference><Reference><Citation>Hirsch HH, Martino R, Ward KN, Boeckh M, Einsele H, Ljungman P. Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus. Clin Infect Dis 2013;56: 258-266.</Citation></Reference><Reference><Citation>Kampf G, Todt D, Pfaender, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect 2020; 104: 246e251.</Citation></Reference><Reference><Citation>Lehners N, Tabatabai JPrifert C et al. Long-term shedding of influenza virus, parainfluenza virus, respiratory syncytial virus and nosocomial epidemiology in patients with hematological disorders. PLoS ONE 2016; 11: e0148258.</Citation></Reference><Reference><Citation>Song YG, Shin HS. COVID-19, A Clinical Syndrome Manifesting as Hypersensitivity Pneumonitis. Infect Chemother 2020; 52: 110-111.</Citation></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Allemagne</li><li>Autriche</li><li>Espagne</li><li>France</li><li>Grèce</li><li>Italie</li><li>Pays-Bas</li><li>Royaume-Uni</li></country><region><li>Angleterre</li><li>Attique (région)</li><li>Communauté de Madrid</li><li>Hollande-Méridionale</li><li>Midlands de l'Ouest</li><li>Piémont</li><li>Vienne (Autriche)</li><li>Île-de-France</li></region><settlement><li>Athènes</li><li>Birmingham</li><li>Leyde</li><li>Madrid</li><li>Paris</li><li>Turin</li><li>Vienne (Autriche)</li></settlement></list><tree><country name="Grèce"><region name="Attique (région)"><name sortKey="Papadavid, E" sort="Papadavid, E" uniqKey="Papadavid E" first="E" last="Papadavid">E. Papadavid</name></region></country><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Scaribrick, J" sort="Scaribrick, J" uniqKey="Scaribrick J" first="J" last="Scaribrick">J. Scaribrick</name></region></country><country name="Espagne"><region name="Communauté de Madrid"><name sortKey="Ortiz Romero, P" sort="Ortiz Romero, P" uniqKey="Ortiz Romero P" first="P" last="Ortiz Romero">P. Ortiz Romero</name></region></country><country name="Italie"><region name="Piémont"><name sortKey="Guaglino, P" sort="Guaglino, P" uniqKey="Guaglino P" first="P" last="Guaglino">P. Guaglino</name></region></country><country name="Pays-Bas"><region name="Hollande-Méridionale"><name sortKey="Vermeer, M" sort="Vermeer, M" uniqKey="Vermeer M" first="M" last="Vermeer">M. Vermeer</name></region></country><country name="Autriche"><region name="Vienne (Autriche)"><name sortKey="Knobler, R" sort="Knobler, R" uniqKey="Knobler R" first="R" last="Knobler">R. Knobler</name></region></country><country name="Allemagne"><noRegion><name sortKey="Stadler, R" sort="Stadler, R" uniqKey="Stadler R" first="R" last="Stadler">R. Stadler</name></noRegion></country><country name="France"><region name="Île-de-France"><name sortKey="Bagot, M" sort="Bagot, M" uniqKey="Bagot M" first="M" last="Bagot">M. Bagot</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B45 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000B45 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidFranceV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32416629
|texte= Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32416629" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidFranceV1
| This area was generated with Dilib version V0.6.37. |  |